Loading viewer...
earnings
Format: PDF earnings
Evonik reported Q3 2016 results with 3% volume growth and adjusted EBITDA of €578 million, supported by strong performance in Specialty & Coating Additives. The company reconfirmed its full-year outlook with adjusted EBITDA expected in the upper half of the €2.0-2.2 billion range. Free cash flow reached €280 million, demonstrating solid cash generation and effective working capital management.
earnings
25 Pages
Bank of New York Mellon
AngloGold Ashanti H1 2016 Results and Financial Performance
earningsearnings
17 Pages
AngloGold Ashanti Limited
Rand Capital Corporation Q3 2023 Financial Results | RAND
earningsearnings
15 Pages
Rand Capital Corporation
Fresenius Medical Care Q1 2024 Earnings Presentation
earningsearnings
26 Pages
Fresenius Medical Care